Literature DB >> 25964330

Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid.

Shang-Yi A Tsai1, Michael J Pokrass2, Neal R Klauer2, Hiroshi Nohara2, Tsung-Ping Su1.   

Abstract

Dysregulation of cyclin-dependent kinase 5 (cdk5) per relative concentrations of its activators p35 and p25 is implicated in neurodegenerative diseases. P35 has a short t½ and undergoes rapid proteasomal degradation in its membrane-bound myristoylated form. P35 is converted by calpain to p25, which, along with an extended t½, promotes aberrant activation of cdk5 and causes abnormal hyperphosphorylation of tau, thus leading to the formation of neurofibrillary tangles. The sigma-1 receptor (Sig-1R) is an endoplasmic reticulum chaperone that is implicated in neuronal survival. However, the specific role of the Sig-1R in neurodegeneration is unclear. Here we found that Sig-1Rs regulate proper tau phosphorylation and axon extension by promoting p35 turnover through the receptor's interaction with myristic acid. In Sig-1R-KO neurons, a greater accumulation of p35 is seen, which results from neither elevated transcription of p35 nor disrupted calpain activity, but rather to the slower degradation of p35. In contrast, Sig-1R overexpression causes a decrease of p35. Sig-1R-KO neurons exhibit shorter axons with lower densities. Myristic acid is found here to bind Sig-1R as an agonist that causes the dissociation of Sig-1R from its cognate partner binding immunoglobulin protein. Remarkably, treatment of Sig-1R-KO neurons with exogenous myristic acid mitigates p35 accumulation, diminishes tau phosphorylation, and restores axon elongation. Our results define the involvement of Sig-1Rs in neurodegeneration and provide a mechanistic explanation that Sig-1Rs help maintain proper tau phosphorylation by potentially carrying and providing myristic acid to p35 for enhanced p35 degradation to circumvent the formation of overreactive cdk5/p25.

Entities:  

Keywords:  axon growth; cdk5; myristic acid; p35; sigma-1 receptor

Mesh:

Substances:

Year:  2015        PMID: 25964330      PMCID: PMC4450430          DOI: 10.1073/pnas.1422001112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  59 in total

1.  Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease.

Authors:  Agnes A Luty; John B J Kwok; Carol Dobson-Stone; Clement T Loy; Kirsten G Coupland; Helena Karlström; Tomasz Sobow; Joanna Tchorzewska; Aleksandra Maruszak; Maria Barcikowska; Peter K Panegyres; Cezary Zekanowski; William S Brooks; Kelly L Williams; Ian P Blair; Karen A Mather; Perminder S Sachdev; Glenda M Halliday; Peter R Schofield
Journal:  Ann Neurol       Date:  2010-11       Impact factor: 10.422

2.  Characterization of a shared epitope in cortical Lewy body fibrils and Alzheimer paired helical filaments.

Authors:  M S Pollanen; C Bergeron; L Weyer
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

3.  Activation of latent cyclin-dependent kinase 5 (Cdk5)-p35 complexes by membrane dissociation.

Authors:  Ying-Shan Zhu; Taro Saito; Akiko Asada; Shohei Maekawa; Shin-ichi Hisanaga
Journal:  J Neurochem       Date:  2005-06-30       Impact factor: 5.372

4.  Function of sigma1 receptors in Parkinson's disease.

Authors:  M Mishina; K Ishiwata; K Ishii; S Kitamura; Y Kimura; K Kawamura; K Oda; T Sasaki; O Sakayori; M Hamamoto; S Kobayashi; Y Katayama
Journal:  Acta Neurol Scand       Date:  2005-08       Impact factor: 3.209

5.  Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39.

Authors:  Seiji Minegishi; Akiko Asada; Shinya Miyauchi; Takahiro Fuchigami; Taro Saito; Shin-Ichi Hisanaga
Journal:  Biochemistry       Date:  2010-07-06       Impact factor: 3.162

6.  Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival.

Authors:  Teruo Hayashi; Tsung-Ping Su
Journal:  Cell       Date:  2007-11-02       Impact factor: 41.582

7.  Low density of sigma1 receptors in early Alzheimer's disease.

Authors:  Masahiro Mishina; Masashi Ohyama; Kenji Ishii; Shin Kitamura; Yuichi Kimura; Kei-ichi Oda; Kazunori Kawamura; Toru Sasaki; Shiro Kobayashi; Yasuo Katayama; Kiichi Ishiwata
Journal:  Ann Nucl Med       Date:  2008-05-23       Impact factor: 2.668

8.  Association between a variant of the sigma-1 receptor gene and Alzheimer's disease.

Authors:  Ágnes Fehér; Anna Juhász; Anna László; János Kálmán; Magdolna Pákáski; János Kálmán; Zoltán Janka
Journal:  Neurosci Lett       Date:  2012-04-25       Impact factor: 3.046

9.  Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival.

Authors:  Tomohisa Mori; Teruo Hayashi; Eri Hayashi; Tsung-Ping Su
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

10.  The therapeutic effects of Rho-ROCK inhibitors on CNS disorders.

Authors:  Takekazu Kubo; Atsushi Yamaguchi; Nobuyoshi Iwata; Toshihide Yamashita
Journal:  Ther Clin Risk Manag       Date:  2008-06       Impact factor: 2.423

View more
  32 in total

Review 1.  The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems.

Authors:  Tsung-Ping Su; Tzu-Chieh Su; Yoki Nakamura; Shang-Yi Tsai
Journal:  Trends Pharmacol Sci       Date:  2016-02-09       Impact factor: 14.819

2.  The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease.

Authors:  Daniel Ryskamp; Jun Wu; Michal Geva; Rebecca Kusko; Iris Grossman; Michael Hayden; Ilya Bezprozvanny
Journal:  Neurobiol Dis       Date:  2016-11-03       Impact factor: 5.996

Review 3.  Sigma-1 Receptors Fine-Tune the Neuronal Networks.

Authors:  Shang-Yi Anne Tsai; Tsung-Ping Su
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 4.  Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection.

Authors:  Linda Nguyen; Brandon P Lucke-Wold; Shona Mookerjee; Nidhi Kaushal; Rae R Matsumoto
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 5.  Peeking into Sigma-1 Receptor Functions Through the Retina.

Authors:  Timur A Mavlyutov; Lian-Wang Guo
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

6.  Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine.

Authors:  Yuko Yasui; Tsung-Ping Su
Journal:  J Drug Alcohol Res       Date:  2016-02-20

7.  Sigma-1 receptor agonist increases axon outgrowth of hippocampal neurons via voltage-gated calcium ions channels.

Authors:  Dong Li; Shu-Zhuo Zhang; Yu-Hong Yao; Yun Xiang; Xiao-Yun Ma; Xiao-Li Wei; Hai-Tao Yan; Xiao-Yan Liu
Journal:  CNS Neurosci Ther       Date:  2017-10-08       Impact factor: 5.243

Review 8.  Hereditary Motor Neuropathies and Amyotrophic Lateral Sclerosis: a Molecular and Clinical Update.

Authors:  Rocio Garcia-Santibanez; Matthew Burford; Robert C Bucelli
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-17       Impact factor: 5.081

9.  AF710B, a Novel M1/σ1 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer’s Disease.

Authors:  Abraham Fisher; Ilya Bezprozvanny; Lili Wu; Daniel A Ryskamp; Nira Bar-Ner; Niva Natan; Rachel Brandeis; Hanoch Elkon; Victoria Nahum; Eitan Gershonov; Frank M LaFerla; Rodrigo Medeiros
Journal:  Neurodegener Dis       Date:  2016       Impact factor: 2.977

10.  Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope.

Authors:  Shang-Yi A Tsai; Jian-Ying Chuang; Meng-Shan Tsai; Xiao-Fei Wang; Zheng-Xiong Xi; Jan-Jong Hung; Wen-Chang Chang; Antonello Bonci; Tsung-Ping Su
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.